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Different Cytokines Induce Surface Lymphotoxin-
on IL-7 Receptor- Cells that Differentially
Engender Lymph Nodes and Peyer’s Patches
gated into specialized regions. On the other hand, PP
can be distinguished from LN by the lack of afferent
lymphatics, as antigens are transported directly through
gut epithelium covering PP.
The two organs also differ with respect to the mole-
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IL-7Rintegrin47 (47) lineage negative surface
phenotype. This population differentiates from fetal
liver-derived progenitor cells and expresses LT uponSummary
stimulation of IL-7R (Yoshida et al., 1999, 2001). The
second population, designated PP organizer (YoshidaThe formation of lymph nodes (LN) and Peyer’s
patches (PP) can be distinguished by the requirement et al., 1999; Honda et al., 2001), is lymphoid organ-
specific mesenchymal tissue (Adachi et al., 1997) thatof RANK for LN but not IL-7R, which is essential
for PP development. However, lymphotoxin- (LT) expresses LTR and is activated by the PP inducer cell
(Hashi et al., 2001; Honda et al., 2001). The IL-7R signal-signaling is required for both organs. The cellular basis
underlying this dichotomy was revealed by the finding ing pathway induces the expression of LT on the PP
inducer cell, which in turn activates a set of cytokines,that the fetal IL-7R population responded equally
well to IL-7 and RANKL to express LT. IL-7R cells adhesion molecules, and chemokines by the PP orga-
nizer, which may be involved in triggering subsequentharvested from TRAF6/ embryos expressed LT in
response to IL-7 but not RANKL, demonstrating that processes (Honda et al., 2001).
In contrast with PP genesis, the sites of where cellularthe RANK-TRAF6 signaling pathway regulates LT
expression in LN but not in PP. Soluble IL-7 adminis- elements interact in the initial phase of lymph node for-
mation have been difficult to identify (Browning et al.,tered to TRAF6/ embryos was sufficient to restore
LN genesis indicating the functional similarities of the 2002). Mebius and colleagues described the presence
IL-7R inducer cells for LN and PP genesis. of a CD4CD3IL-7R cell population in neonatal LN,
which appears to be very similar if not identical to the PP
Introduction inducer cell (Mebius et al., 1996, 1997). This population
expresses 47, c-kit, and LT, but no lineage markers
Lymph nodes (LN) and Peyer’s patches (PP) constitute (Mebius et al., 1997) and RANK, which suggests its role
the major portion of the peripheral lymphoid system in RANKL-dependent LN genesis (Kim et al., 2000).
where distinct cell lineages selectively gather and inter- Given that LT-expressing cells distributed in the de-
act with each other to initiate immune defenses. While veloping LN (Mebius et al., 1997) are indistinguishable
the two organs share many common features, they are in surface phenotype from the population identified as
also distinct in several aspects. For instance, the cellular the PP inducer, it is likely that the dichotomy of molecu-
microarchitecture of the two organs is similar in that a lar requirements for organogenesis of LN and PP can
number of cell types including lymphocytes are segre- be ascribed to differences in the action or location of
the cytokines initiating organogenesis. Alternatively, the
differential expression or compartmentalization of cells6 Correspondence: hyoshida@virus.kyoto-u.ac.jp
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Figure 1. Visualization of Lymph Node An-
lagen
Presumptive lymph node regions were de-
tected by whole-mount immunostaining with
anti-IL-7R antibody. The arrows in (A)–(H)
indicate the IL-7R cells migrated to LN an-
lagen at mandibular region (A), parathymic
region (B), axillary region (C), mesenteric re-
gion (D), detected along both inferior and su-
perior mesenteric artery (E), inguinal region
(F), and paraaortic region (G). (H) indicates
that the position of PP (white arrowheads)
and mesenteric LN (arrows) are detectable by
the same experiment at once. A schematic
picture in the bottom indicates the localiza-
tion of LN anlagen in relation to the position of
major organs and arteries in mouse embryo.
Note that the shape and size of the organs,
arteries, and LN anlagen are deformed for
gaining better orientation. AG, adrenal gland;
Ao, aorta; Bl, bladder; Ea, ear bud; FL, fore
limb; Ge, genitalia; H, heart; HL, hind limb; In,
intestine; Ki, kidney; Li, liver; Lu, lung; Ma,
mandible; PP, Peyer’s patch; St, stomach; Th,
thymus; Ur, ureter; Ut, uterus.
expressing RANKL and the ligand for IL-7R could give from surrounding tissues by the accumulation of IL-
rise to their distinct roles in organogenesis. 7R cells and expression of VCAM-1 in the mesen-
The results presented here indicate that the inducer chyme. The localization of nascent LN anlagen in the
cells for PP and LN are found in a functionally and pheno- maxillary (Figure 1A), parathymic (Figure 1B), axillary
typically similar population of cells. The inducer popula- (Figure 1C), mesenteric (Figures 1D, 1E, and 1H), inguinal
tion that initiates LN genesis is responsive to both (Figure 1F), and paraaortic regions (Figure 1G) was visu-
RANKL and IL-7 for the induction of surface LT. A alized as clusters of IL-7R cells, which were also ob-
consequence of the similar response of the cells to these served for PP anlagen (white arrowheads in Figure 1H)
ligands is demonstrated by the ability of IL-7 adminis- as previously described (Adachi et al., 1997). The earliest
tered to TRAF6-deficient embryos, which lack the stage at which the accumulation of IL-7R cells be-
RANK-signaling pathway, to trigger LN genesis. came detectable was between 12.5 to 13.5 days post-
coitus (dpc) for all LN examined with an ontogenic hierar-
chy of appearance in the anterior to posterior direction,Results
whereas the PP anlagen appears late at 15.0 dpc (Adachi
et al., 1997). Thus, accumulation of IL-7R cells allowsVisualizing LN Genesis
identification of nascent LN anlagen in most compart-The PP anlagen are distinguished from surrounding tis-
ments of the embryonic body. IL-7R cells accumu-sues by the accumulation of IL-7R inducer cells that
lated in the paraaortic region at 12.5–13.0 dpc (Figureexpress LT and by the presence of VCAM-1ICAM-1
2A), whereas VCAM-1 expression emerged at 13.0–13.5mesenchymal cells that respond to LT (Adachi et al.,
dpc (Figure 2B). Although VCAM-1 was expressed along1997, Yoshida et al., 1999; Honda et al., 2001). We rea-
soned that the LN anlagen could also be distinguished veins in this region, the strongest expression was ob-
IL-7R Inducers for PP and LN Organogenesis
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Figure 2. Expression of the VCAM-1 in LN
Anlagen and Its Absence in LT/ Embryos
(A) Accumulation of IL-7R cells in nascent
paraaortic LN of a 13.5 dpc embryo. Expres-
sion of VCAM-1 (B), CD45 (C), and PECAM-
1 (D) in the same region of embryos at 13.5
dpc. Note that VCAM-1 expression was found
in the same region where IL-7R cells accu-
mulated (indicated by white arrows in [A] and
[B]). Note that both IL-7R cells and VCAM-
1 cells are present in the mesenchymal re-
gion between the aorta and adjacent large
veins. IL-7R cells migrated into the extra-
vascular region between the artery and vein
([E], arrowheads). (F) IL-7R cells were also
detectable in the paraaortic LN anlagen re-
gion of the LT/ embryo at 13.5 dpc similar
to that of wild-type embryo (A). (G) In LT/
embryos, VCAM-1 expression in the region
where IL-7R cells accumulated is not de-
tected (indicated by arrows). The presence of
a VCAM-1 mesenchymal region other than
LN anlagen was assessed in (G). AG, adrenal
gland; Ao, aorta; Go, gonad; Ki, kidney.
served in the putative LN anlagen (Figure 2B, white patches (Yoshida et al., 1999). Similar results were ob-
served in NIKaly homozygous embryos (data not shown),arrows). Visualization of leukocytes by staining for CD45
(Figure 2C) and vascular networks for expression of which coincide with the essential role of NIK in LTR
signaling (Dejardin et al., 2002). These results indicatePECAM-1 (Figure 2D) demonstrated that IL-7R cells
specifically distribute along the large veins. Indeed, sec- that the migration of IL-7R cells to the presumptive
LN anlagen is independent from the subsequent requi-tions showed numerous IL-7R cells attached to the
luminal surface of veins and in the process of extravasa- site role of LT.
tion (Figure 2E) suggesting that the extravasations may
correspond to developing LN anlagen. To determine Induction of LT on IL-7R Inducer Cells
The histological analysis of the early phase of LN genesiswhether these histological observations correlate spe-
cifically to the process of LN genesis, we analyzed em- suggested that IL-7R cells accumulating in the LN
anlagen are the LT-expressing cells, which inducebryos from LT/ mice, which are defective in LN for-
mation. As expected, in spite of the migration of IL-7R VCAM-1 in the surrounding mesenchymal cells. IL-7R
cells in the mesenteric LN and intestine have a similarcells to the paraaortic LN anlagen (Figure 2F), VCAM-1
expression in the putative LN anlagen was not observed surface phenotype; both express IL-7R47c-
KitCD3 (Figures 3A and 3C and data not shown). Inin LT/embryos (Figure 2G), which is similar to Peyer’s
Immunity
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addition, cells expressing both VCAM-1ICAM-1 were
detected in both organs (Figures 3B and 3D). These
observations suggested that the mesenteric and intes-
tine IL-7R populations might be responsive to either
IL-7 or RANK ligand as measured by the expression of
surface LT. To test the functional similarity of these
two populations, IL-7R cells were isolated either from
the intestine or the mesentery, rested in culture to allow
endogenous levels of LT to subside (Yoshida et al.,
2001), and then stimulated with different cytokines.
Treatment with IL-7 or RANK ligand for 12 hr induced
cell surface LT equally well in both populations (Fig-
ures 4A and 4B). Interestingly, TNF and TPO also
showed some capacity to induce LT, although to a
lesser extent. By contrast, IL-5, LIF, bFGF, and EGF
were not effective in inducing LT. In support of the
idea that RANKL is a key inducer of LT, we identified
RANKL expression in the LN anlagen (Figure 4C), al-Figure 3. IL-7R47 and VCAM-1ICAM-1 Populations in De-
veloping PP and LN though not in the intestine (data not shown). It was not
Single-cell suspensions were obtained from developing intestine (A technically possible to detect either IL-7 or thymic stromal
and B) or mesentery (C and D) of 17.5 dpc embryos, and the propor- lymphopoietin (TSLP), a second ligand the binds IL-7R,
tion of IL-7R47 (A and C) and VCAM-1ICAM-1 (B and D) by immunostaining or in situ hybridization, although
populations was measured by flow cytometry. This data is represen-
mRNA was weakly detectable by RT-PCR (data nottative of five independent experiments.
shown).
Figure 4. RANKL and IL-7 Induce LT in IL-
7R Cells
IL-7R cells obtained from the intestine (A)
or mesentery (B) of 17.5 dpc wild-type em-
bryos were cultured with IL-6 and SCF for 3
days. By this procedure, LT expression of
IL-7R cells subsided to background levels.
The cultured cells were stimulated by various
cytokines for 12 hr and LT expression was
measured by staining with LTR-Fc. (C) Ex-
pression of RANKL in paraaortic LN anlagen
detected by whole-mount immunohistostain-
ing with anti-mouse RANKL. Ki, kidney; AG,
adrenal gland; Ao, aorta.
IL-7R Inducers for PP and LN Organogenesis
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Figure 5. Absence of VCAM-1 Expression in LN Anlagen of TRAF6/ Embryos
VCAM-1 expression in PP and LN anlagen of control and TRAF6/ mice was examined. While the appearance of VCAM-1 regions is detected
in PP anlagen of both control (A) and TRAF6/ (B) embryos (indicated by arrows), VCAM-1 cell aggregates that are found in control embryos
([C], arrows) cannot be detected in the TRAF6/ embryos ([D], arrows). Formation of LN anlagen in TRAF6/ embryos was visualized by the
accumulation of IL-7R cells ([E], arrows). (F) The above histological observations were confirmed by the flow cytometer analysis of the
proportion of IL-7R47 cells and VCAM-1ICAM-1 cells in developing LN and PP. In the 15.5 dpc embryos, IL-7R47 cells are
found in both the intestine and mesentery of TRAF6/ embryos as well as control embryos. While the proportion of IL-7R47 cells in
the intestine of 17.5 dpc embryos does not differ between control and TRAF6/ embryos, those in the mesentery of the same embryos are
reduced in TRAF6/ embryos. Reduction of VCAM-1ICAM-1 population in TRAF6/ embryos is more striking. Ki, kidney; Ao, aorta; AG,
adrenal gland.
Analysis of PP and LN Genesis in TRAF6/ Embryos Cell surface marker analysis of cells in the intestine
The previous results suggested that localized expres- or mesentery from 15.5 or 17.5 dpc TRAF6/ or control
sion of RANKL activates LTproduction by the IL-7R mice revealed the proportion of IL-7R47 cells har-
inducer cells, which accumulate in forming LN anlagen. vested from the intestine or mesentery at 15.5 dpc did
To determine where RANKL acts relative to the LT not differ between TRAF6/ and control embryos; how-
signaling pathway, we analyzed TRAF6/ mice. TRAF6- ever, at 17.5 dpc, the proportion of IL-7R47 de-
deficient mice, like RANK/ mice, fail to develop LN, creased in the mesentery but not in the intestine of
although PP genesis is unaffected (Naito et al., 1999) TRAF6/ fetuses. A striking reduction was observed
indicating that TRAF6 is likely to be involved in RANK in the VCAM-1ICAM-1 cells in the mesentery of
signaling (Kong et al., 1999) but unlikely to be involved in TRAF6/ embryos, whereas those in the intestine were
LTR-dependent processes. Peripheral lymphoid organ comparable in both groups. Thus, the absence of TRAF6
development was examined in TRAF6/ fetuses by results in the LN-specific inhibition of the differentiation
means of whole-mount immunostaining. As was ex- of VCAM-1ICAM-1 mesenchymal cells.
pected from the previous findings, development of PP
anlagen was comparable between the heterozygous
Reconstitution of LN Genesis by IL-7control (Figure 5A) and the homozygous TRAF6/ fe-
IL-7R cells freshly isolated from TRAF6/ embryostuses (Figure 5B). In contrast, while discrete VCAM-1
expressed LT in the intestine but not in the mesenteryLN anlagen developed in the paraaortic region of control
(Figures 6A–6D), suggesting that RANK signaling is nec-mice at 18.5 dpc (Figure 5C), VCAM-1 expression was
essary for induction of LT expression. To determineundetectable in the TRAF6/ paraaortic LN region (Fig-
if RANK signaling requires TRAF6 for induction of LTure 5D). Note that VCAM-1 expression in other tissues
expression, isolated IL-7R cells from the intestine andsuch as the veins and kidneys was normal (Figure 5D).
mesentery of TRAF6/ or control embryos (rested inIn contrast, IL-7R cells accumulated in the paraaortic
culture in the presence of SCF and IL-6 to decreaseLN region of TRAF6/ fetuses, suggesting that the rudi-
endogenous levels of LT) were stimulated withmentary LN anlagen are formed in these mice (Figure
5E, arrows). RANKL or IL-7, and the induction LT was measured
Immunity
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by flow cytometry. As predicted, IL-7R cells from
TRAF6/ embryos responded to IL-7 but not RANKL,
whereas cells from control embryos responded to both
cytokines (Figure 6E). These results indicate that IL-7
suffices as a ligand for LT induction in IL-7R cells
in the absence of RANK-TRAF6 signaling.
To determine whether IL-7 can substitute for RANKL
in vivo, IL-7 was injected directly into embryos at 13.5
and 14.5 dpc, when the IL-7R cells have accumulated
in the LN anlagen. A single injection of IL-7 induced
VCAM-1 expression in the peripheral or mesenteric LN
anlagen of TRAF6/ mice (Figures 7A and 7B), compa-
rable with that of control mice, that subsequently devel-
oped into large VCAM-1 regions (Figure 7C). Live-born
mice that had been treated with IL-7 at 14.5 dpc and
survived for 10 days after birth developed discrete LN
in the mesentery, filled with T and B cells and with high
endothelial venules identified by the expression of MAd-
CAM-1 and PNAd (Figures 7E and 7K–7O, compare
with Figures 7D and 7F–7J). Thus, IL-7 can substitute for
RANKL in triggering the early processes of LN genesis.
We note, however, that TRAF6/ LN rescued by IL-7
differed from normal LN in several aspects. Control LN
display a lymphocyte-rich architecture surrounded by
endothelial vessels (Figure 7D, arrows), B cells reside
in the follicles (Figure 7F) that are segregated from the
interfollicular T cells (Figure 7G), and PNAd (Figure 7H)
and MAdCAM-1 (Figure 7I) high endothelial venules
(HEV) are present. By contrast, although both T and B
cells were present in the IL-7-rescued LN of TRAF6/
mice, they are not segregated into discrete zones, and
the proportion of mesenchymal cells appears more
abundant (Figure 7E, arrowheads) than in control LN
(Figure 7D). Moreover, the PNAd and MAdCAM-1 ves-
sels formed in the IL-7-rescued TRAF6/ LN lacked
clearly defined B cell follicles (Figure 7K), and CD3 T
cells are the predominate population in the LN (Figure
3L). Additionally, follicular dendritic cells identified with
FDC-M1 were also absent in IL-7-rescued TRAF6/
LN (compare Figures 7J and 7O). These results indicate
that, although IL-7 is sufficient to replace RANKL in
triggering the early process of LN genesis, TRAF6 is
required to propagate signals required to establish a
higher ordered microarchitecture of LN.
Discussion
The results presented here indicate that IL-7R cells
involved in the formation of LN and PP are functionally
interchangeable populations within the context of re-
sponding to distinct cytokine signals, RANKL, or ligands
Figure 6. RANKL-Specific Impairment of LT Expression in IL-7R for IL-7R, by production of LT. Accumulating evi-
Cells from TRAF6/ Embryos
dence indicates that the cell lineage involved in both
Single-cell suspensions were prepared from either TRAF6/ or con-
LN and PP genesis is derived from a common precursor.trol embryos and analyzed for surface molecules. IL-7R47
First, the fetal cells that produce LT in both LN andcells were gated, and LT expression of the gated population was
PP have a similar surface phenotype; both express IL-7R,measured by LTR-Fc. LT expression was comparable between
control and knockout mouse IL-7Ra cells in the intestine (A and 47, c-kit, and CD4, but not lineage-specific markers
B) but was impaired in the cells harvested from the mesentery of (Mebius et al., 1997; Yoshida et al., 1999). Second, these
TRAF6/ mice (D) in contrast with that of control mesentery (C). cells develop via the same differentiation pathway and
IL-7R cells were harvested from the intestine (E and F) or mesen-
are derived from IL-7R lymphoid precursors. This pre-tery (G and H) of control and TRAF6/ mice. Cells were rested in
cursor population also gives rise to both NK and den-culture for 3 days with IL-6 and SCF to downregulate LT expres-
dritic cells (Mebius et al., 1997, 2001; Yoshida et al.,sion prior to treatment with IL-7 or RANKL for 12 hr.
2001). Finally, a similar set of transcriptional regulators
IL-7R Inducers for PP and LN Organogenesis
829
Figure 7. Restoration of LN Genesis of TRAF6/ Mouse by Intraembryonic Injection of IL-7.
At 13.5–14.5 dpc, 10 U of IL-7 was injected into fetus through the uterine wall. The fetal tissue was harvested at 17.5 dpc, and the development
of LN anlagen was examined by means of anti-VCAM-1 whole-mount immunostaining. Nine out of twelve TRAF6/ mice injected with IL-7
developed LN-like cell aggregates in the embryonic mesentery. We also prepared control TRAF6/ mice that were injected with PBS, IL-6,
and RANKL to restore LN genesis. None of the TRAF6/ embryos receiving PBS (four mice), IL-6 (two mice), and RANKL (two mice) developed
LN-like cell aggregates. Presented result in (A)–(C) is a representative picture of those independent experiments. VCAM-1 is induced by IL-7
injection in the LN anlagen (B) at the level comparable to the LN anlagen of control embryos (A). Discrete cell aggregates are detected
histologically in these LN anlagen (C). Ki, kidney; Ao, aorta. Three litters of IL-7-injected embryos were analyzed 10 days after birth. Only
three TRAF6/ mice among three litters that received IL-7 injection survived up to day 10 after birth. LN-like structures developed in all three
mice. A VCAM-1 LN anlagen from one IL-7 injected control or TRAF6/ mouse was sectioned and HE stained (D)–(O). (D and F–J) Mesenteric
LN from control mice and (E and K–O) those from TRAF6/ mice rescued by the IL-7 injection. HE staining (D and E), B220 expression (F
and K), CD3 expression (G and L), MAdCAM-1 expression (H and M), PNAd expression (I and N), and FDC-M1 expression (J and O). Arrows
in (D) and (E) indicate the subcapsular space development. Arrowheads in (E) indicate the mesenchymal cells found only in IL-7-rescued
mutant LN. AG, adrenal gland; Ao, aorta; Ki, kidney.
are involved in development of these LT-producing tional properties are controlled by local microenviron-
ments that dictate the preference for RANKL or IL-7Rcells in both organs. Analyses of mice deficient in Ikaros
(Georgopoulos et al., 1994), Id2 (Yokota et al., 1999), ligands.
Histological analyses demonstrated that IL-7R cellsand ROR (Sun et al., 2000) demonstrated that the failure
of PP and LN genesis in these mutant mice is due to the specifically distribute and cluster along the large veins
at the putative LN anlagen. This LN-specific distributionarrest of the differentiation of both LN and PP inducers.
Taken together, it is highly likely that a common cell pattern of IL-7R cells contrasts to the diffuse distribu-
tion of CD45 hematopoietic cells in the same regionpopulation regulates LN and PP genesis, and the func-
Immunity
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and suggests that the migration of IL-7R cells is regu- RANKL signaling, indicating that the expression of the
lated by specific trafficking mechanisms controlled in ligands for IL-7R is crucial for PP and that RANKL cannot
part by chemokines. In this regard, BLC is a potent reciprocally supplant IL-7. Nonetheless, the IL-7/ mouse
chemoattractant of IL-7R cells (Honda et al., 2001), has a normal complement of PP (our unpublished data)
BLC is concentrated in this region, and the accumulation implying another possibly redundant cytokine serves
of IL-7R cells is completely absent in BLC/ mice (our this function. TSLP binds IL-7R and is thus a likely
unpublished data). The formation of a BLC region early candidate, although C and Jak3 are not required for
in LN genesis may direct the migration of IL-7R cells some signaling activities (Isaksen, et al., 1999, 2002;
to this region. Although LT heterotrimers can induce Pandey, et al., 2000), raising the intriguing possibility of
expression of chemokines including BLC (Cuff et al., yet another IL-7-like ligand. A further complexity in the
1999; Honda et al., 2001; Luther et al., 2000; Dejardin ligands regulating LN development was revealed by Kim
et al., 2002) and BLC reciprocally regulates LT pro- et al. (2000) who described in their discussion that the
duction, the accumulation of IL-7R cells occurs in injection of an agonistic anti-LTR mAb during em-
LT/ mice indicating that other mechanisms control bryogenesis failed to restore LN in RANKL/ mice, de-
expression of BLC. spite the ability of this antibody to restore LN in LT/
Following accumulation of IL-7R cells in the LN mice (Rennert et al., 1998). This result together with the
anlagen, the process of LN and PP genesis appears to demonstration that IL-7 is competent to restore LN in
follow a parallel path (Nishikawa et al., 1998). Namely, RANKL/ mice suggests that activation of the IL-7R
an organ-specific cytokine stimulates IL-7R cells to inducer cells may elicit additional signals that cooperate
express LT, which then activates the surrounding with LT in the formation of the complete LN structure.
LTR mesenchymal cells to express adhesion mole- Although the initial phase of LN genesis can be trig-
cules, cytokines, and chemokines that orchestrate sub- gered by embryonic injection of IL-7, the cellular mi-
sequent processes of organogenesis (Honda et al., croarchitecture of LN did not develop beyond unorga-
2001). In this study, we showed that VCAM-1ICAM-1 nized cell aggregates, even though a vascular system
mesenchymal cells were found in both PP and LN, but with MAdCAM-1 vessels was formed. This is consistent
this population is lost specifically from LN anlagen by with previous studies indicating LT functions in the
disruption of the RANK signal transduction pathway, development of higher order architecture of peripheral
supporting the idea that RANKL induces expression of lymphoid tissue, and continued signaling may be re-
LT on IL-7R inducer cells in the nascent LN anlage. quired for the maintenance of the tissue architecture
The conditions required for the expression of LT in (Fu et al., 1997; Gonzalez et al., 1998). IL-7, acting as
the LN and PP inducers of these organs are distinct an alternative signal for RANKL, only partially restored
in that RANK and IL-7R signals are specifically but LN genesis in TRAF6/ mice, indicating that TRAF6-
differentially required for LN and PP genesis. However, propagated signals, including those upstream of RANK,
the results clearly showed that IL-7R cells, derived are involved in the formation of the higher order miroar-
from either LN or PP, respond equally well to IL-7 or chitecture of LN. Moreover, it is possible that IL-7R
RANKL for the induction of LT. Most strikingly, LN cells continue to play a role in this late phase of LN
genesis in TRAF6/ mice was restored by a single in- genesis. In this context, further comparison of LN archi-
traembryonic injection of IL-7 at 13.5–14.5 dpc indicat- tecture restored in LT/ mice by the agonistic anti-
ing that IL-7 and RANKL are functionally equivalent, LTR and in TRAF6/ mice by IL-7 will be useful to
even though their receptors activate distinct signaling discriminate the cellular events required for this late
pathways. These results imply that these two cytokines phase of LN genesis.
are not globally available in the embryo but their bioavail-
ability is compartmentalized. Certainly for RANKL its
Experimental Proceduresstructure as a type II transmembrane protein can restrict
its availability, yet IL-7 is a secreted soluble protein, Mice
although not readily detectable in biological milieu. Un- Pregnant C57BL/6J mice were purchased from Japan SLC (Shizu-
derstanding the mechanism controlling IL-7 compart- oka, Japan). Mating was conducted overnight, and noon of the day
when vaginal plugs were identified was calculated as 0.5 (dpc).mentalization may yield new insight into its control of
organogenesis.
The injection of IL-7 not only restored LN genesis but Antibodies and Recombinant LTR-Fc Chimeric Protein
Anti-IL-7R (A7R34) and anti-c-Kit (ACK2) antibodies were establishedresulted in a rapid induction of VCAM-1 expression in
in our laboratory and prepared as previously described (Nishikawa etthe putative LN anlagen, indicating that LTproduction
al., 1991, Sudo et al., 1993). Anti-B220 (RA3-6B2), anti-CD11bby IL-7R cells in the LN anlagen can be stimulated
(Mac-1), anti-CD8 (53-6.7), and anti-F4/80 (F4/80) were purified
by IL-7, which then activates the surrounding mesenchy- from hybridoma culture supernatants as described (Nishikawa et
mal cells via LTR to express VCAM-1. Although the al., 1991). Anti-Thy-1.2 was purchased from CALTAG (San Fran-
initial analysis of C/ and Jak3/ mice indicated that cisco, CA), anti-CD3 (Y65.135) from Seikagakukogyo (Tokyo, Japan),
LN and PP were absent (Cao et al., 1995; Park et al., anti-integrin 47 heterodimer (DATK32), anti-CD3 (2C11), anti-CD4
(GK1.5), anti-CD11c (HL3), anti-TCR- (H57-597), anti TCR-1995), a closer examination using whole-mount immu-
(GL3), anti-CD45 (30F11.1), anti-NK1.1 (NKR-P1C), anti-Gr-1 (RB6-nostaining revealed normal expression of VCAM-1 in the
8C5), anti-MAdCAM-1 (MECA-367), anti-PECAM-1 (MEC13.3), anti-LN anlage (our unpublished data), which because of the
PNAd (MECA-79), and anti-FDC (FDC-M1) were from Pharmingen
lymphopenia fail to fill with lymphocytes giving the false (San Diego, CA); goat anti-RANKL was from Santa Cruz Biotechnolo-
appearance of the organ’s absence. We conclude that gies (Santa Cruz, CA) and anti-rat immunoglobulin (HL) goat serum
the role of IL-7R signaling in LN genesis is minimal. In was from Biosource International (Camarillo, CA).
The extracellular domain of the LTR was fused to the Fc region ofcontrast, PP genesis clearly occurs in the absence of
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human IgG1 (Force et al., 1995), expressed in baculovirus (Invitrogen, ceed until the desired color intensity was reached, and specimens
were rinsed three to four times in PBST.Groningen, The Netherlands) and purified by protein G affinity chro-
matography as described (Crowe et al., 1994). This chimeric protein For staining of sections, fixed specimens were embedded in poly-
ester wax or OCT compound, microtome sectioned, and stainedwas used in flow cytometric analysis to detect membrane-anchored
LT12 with biotinylated goat anti-human IgG (Southern Biotechnol- with hematoxylin and eosin or immunostained with mAbs listed
above.ogy Associates, Birmingham, AL) as the secondary reagent, fol-
lowed by streptavidin conjugated with allophycocyanine (Molecular
Probe, Eugene, OR). For a negative control, we used a fusion protein Genotyping
containing the extracellular domain of platelet-derived growth factor Genotyping of TRAF6 transgenic animals was performed by PCR
receptor  (PDGFR) and human IgG1 Fc portion (Takakura et al., amplification of genomic DNA with the following set of primers:
1996). exon3, 5-CGT GCC ATG TAA TGC ATT CTG TTG TTG CAG-3;
neomycin, 5-TAC AGA CAC TCA GCA CCA TTT CCT AAC CTG-3;
Preparation of Single-Cell Suspension for Flow Cytometry exon4, 5-TGA TGA TCC TCG AGA TGT CTC AGT TCC ATC-3. This
and Cell Sorting primer set produced bands of 256 bp in length from wild-type and
Embryonic organs were dissected under stereomicroscopy and dis- 187 bp from transgenic animals. Genotype of TRAF6 KO mice was
sociated by dispase (GIBCO-BRL, Grand Island, NY) incubation for also confirmed by the absence of guard hair follicles (Naito et al.,
10–25 min at 37	C. After gentle pipetting, dissociated cells were 2002) under dissection microscope. Throughout this study, only
washed with Hanks balanced salt solution containing 20% fetal calf heterozygous mice were used as the control against TRAF6/ em-
serum and DNase (Sigma, St. Louis, MO). Cells were filtered through bryos.
nylon mesh to remove large clumps, washed, and stained with mAbs
as described (Sudo et al., 1993). These cells were analyzed or sorted Acknowledgments
by FACS Vantage (Beckton Dickinson, Lincoln Park, NJ).
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